MedTrace Logo

The Medacta GMK SpheriKA Post-Marketing Surveillance Study

NCT05459948 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 281

Last updated 2025-09-29

No results posted yet for this study

Summary

This is a Post-Marketing Surveillance of GMK SpheriKA knee stem prosthesis.

Conditions

  • Arthropathy
  • Knee Replacement

Interventions

DEVICE

GMK SpheriKA

The first objective is to study the FJS of patients who were implanted a "GMK® SpheriKA" knee prosthesis using the kinematic alignment technique

Sponsors & Collaborators

  • Medacta International SA

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-30
Primary Completion
2035-05-31
Completion
2035-05-31

Countries

  • France
  • Italy
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05459948 on ClinicalTrials.gov